LAWRENCE BRIAN 4
4 · VAPOTHERM INC · Filed Feb 29, 2024
Insider Transaction Report
Form 4
VAPOTHERM INCVAPO
Lawrence Brian Lee
SVP & Chief Technology Officer
Transactions
- Award
Stock Option (right to buy)
2024-02-27+3,550→ 3,550 totalExercise: $0.92Exp: 2032-01-01→ Common Stock (3,550 underlying) - Disposition to Issuer
Stock Option (right to buy)
2024-02-27−3,550→ 0 totalExercise: $165.68Exp: 2032-01-01→ Common Stock (3,550 underlying) - Disposition to Issuer
Stock Option (right to buy)
2024-02-27−6,834→ 0 totalExercise: $21.60Exp: 2033-01-02→ Common Stock (6,834 underlying) - Award
Stock Option (right to buy)
2024-02-27+6,834→ 6,834 totalExercise: $0.92Exp: 2033-01-02→ Common Stock (6,834 underlying) - Disposition to Issuer
Stock Option (right to buy)
2024-02-27−6,625→ 0 totalExercise: $25.28Exp: 2032-05-10→ Common Stock (6,625 underlying) - Award
Stock Option (right to buy)
2024-02-27+6,625→ 6,625 totalExercise: $0.92Exp: 2032-05-10→ Common Stock (6,625 underlying)
Holdings
- 60,188
Common Stock
Footnotes (5)
- [F1]Includes 37,319 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Vapotherm, Inc. Amended and Restated 2018 Equity Incentive Plan.
- [F2]This option vested as to 25% of the underlying shares on January 1, 2023 and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, provided that the Reporting Person continues to serve as an employee or other service provider to the Issuer on each vesting date and otherwise subject to the Issuer's applicable equity incentive plan.
- [F3]The transactions reported herein reflect a stock option repricing effective February 27, 2024 pursuant to which the exercise price of the repriced options was amended to reduce the exercise price to $0.915 per share, the closing price of the Issuer's common stock on February 27, 2024. There is no change to the expiration dates or the vesting schedule of the repriced options.
- [F4]This option vested as to 25% of the underlying shares on January 1, 2024, and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, provided that the Reporting Person continues to serve as an employee or other service provider to the Issuer on each vesting date and otherwise subject to the Issuer's applicable equity incentive plan.
- [F5]This option vested as to 25% of the underlying shares on January 2, 2024, and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, provided that the Reporting Person continues to serve as an employee or other service provider to the Issuer on each vesting date and otherwise subject to the Issuer's applicable equity incentive plan.